Guardant Health (GH) Equity Average (2018 - 2026)

Guardant Health has disclosed Equity Average across 9 years of filings, most recently posting -$140.2 million for Q1 2026.

• Equity Average for Q1 2026 came in at -$140.2 million, up 28.19% year-over-year; the trailing twelve-month figure through Mar 2026 was -$140.2 million (up 28.19% YoY), and the FY2025 annual result was -$119.5 million, down 1355.21% from the prior year.
• Equity Average came in at -$140.2 million for Q1 2026 at Guardant Health, up from -$226.9 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $589.0 million in Q1 2022 to a low of -$330.0 million in Q3 2025.
• The 5-year median for Equity Average is $33.3 million (2024), against an average of $47.2 million.
• Across the five-year window, Equity Average jumped 1352.23% in 2024 and slumped 969.45% in 2025, its largest moves.
• Guardant Health's Equity Average stood at $113.5 million in 2022, then jumped by 70.53% to $193.5 million in 2023, then sank by 151.62% to -$99.9 million in 2024, then tumbled by 127.18% to -$226.9 million in 2025, then jumped by 38.21% to -$140.2 million in 2026.
• The last three Equity Average figures came in at -$140.2 million (Q1 2026), -$226.9 million (Q4 2025), and -$330.0 million (Q3 2025), per Business Quant data.